» Articles » PMID: 21726443

Is the Beck Anxiety Inventory a Good Tool to Assess the Severity of Anxiety? A Primary Care Study in the Netherlands Study of Depression and Anxiety (NESDA)

Overview
Journal BMC Fam Pract
Publisher Biomed Central
Date 2011 Jul 6
PMID 21726443
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Appropriate management of anxiety disorders in primary care requires clinical assessment and monitoring of the severity of the anxiety. This study focuses on the Beck Anxiety Inventory (BAI) as a severity indicator for anxiety in primary care patients with different anxiety disorders (social phobia, panic disorder with or without agoraphobia, agoraphobia or generalized anxiety disorder), depressive disorders or no disorder (controls).

Methods: Participants were 1601 primary care patients participating in the Netherlands Study of Depression and Anxiety (NESDA). Regression analyses were used to compare the mean BAI scores of the different diagnostic groups and to correct for age and gender.

Results: Patients with any anxiety disorder had a significantly higher mean score than the controls. A significantly higher score was found for patients with panic disorder and agoraphobia compared to patients with agoraphobia only or social phobia only. BAI scores in patients with an anxiety disorder with a co-morbid anxiety disorder and in patients with an anxiety disorder with a co-morbid depressive disorder were significantly higher than BAI scores in patients with an anxiety disorder alone or patients with a depressive disorder alone. Depressed and anxious patients did not differ significantly in their mean scores.

Conclusions: The results suggest that the BAI may be used as a severity indicator of anxiety in primary care patients with different anxiety disorders. However, because the instrument seems to reflect the severity of depression as well, it is not a suitable instrument to discriminate between anxiety and depression in a primary care population.

Citing Articles

Five-year trajectories of symptom severity, physical and mental functioning in patients with persistent somatic symptoms: the PROSPECTS cohort study.

Barends H, van der Horst H, van der Wouden J, Claassen N, Dekker J, Hoekstra T BMJ Open. 2025; 15(1):e083276.

PMID: 39779277 PMC: 11749328. DOI: 10.1136/bmjopen-2023-083276.


Screening and Assessment for Psychological Distress among Burn Survivors.

Loehr V, Goette W, Roaten K Eur Burn J. 2024; 3(1):57-88.

PMID: 39604177 PMC: 11575395. DOI: 10.3390/ebj3010008.


The prevalence of depression and anxiety in premenopausal and menopausal women: A cross-sectional study.

Vaziri-Harami R, Kazemi S, Vaziri-Harami S, Hazari V, Farokh P, Valadbeigi T Health Sci Rep. 2024; 7(7):e2267.

PMID: 39044847 PMC: 11263131. DOI: 10.1002/hsr2.2267.


Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life.

Gupta A, Johnson S, Barraclough M, Su J, Bingham K, Knight A Lupus Sci Med. 2024; 11(2).

PMID: 38991833 PMC: 11243126. DOI: 10.1136/lupus-2023-001006.


Anxiety, a significant risk factor for coronary artery disease: what is the best index.

Rezaee M, Darroudi H, Etemad L, Shad A, Zardast Z, Kohansal H BMC Psychiatry. 2024; 24(1):443.

PMID: 38877499 PMC: 11177367. DOI: 10.1186/s12888-024-05798-w.


References
1.
Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S . Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ. 2009; 338:b750. DOI: 10.1136/bmj.b750. View

2.
Muntingh A, van der Feltz-Cornelis C, van Marwijk H, Spinhoven P, Assendelft W, de Waal M . Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial. BMC Health Serv Res. 2009; 9:159. PMC: 2753326. DOI: 10.1186/1472-6963-9-159. View

3.
Dowrick C, Leydon G, McBride A, Howe A, Burgess H, Clarke P . Patients' and doctors' views on depression severity questionnaires incentivised in UK quality and outcomes framework: qualitative study. BMJ. 2009; 338:b663. DOI: 10.1136/bmj.b663. View

4.
Brown T, Barlow D . A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess. 2009; 21(3):256-71. PMC: 2845450. DOI: 10.1037/a0016608. View

5.
Beck A, Epstein N, Brown G, Steer R . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56(6):893-7. DOI: 10.1037//0022-006x.56.6.893. View